DFP Healthcare Acquisitions Cor

DFP Healthcare Acquisitions Cor

DFPH
DFP Healthcare Acquisitions CorUS flagOther OTC
2.01
USD
- -
- -
436.37MMarket Cap
DFP Healthcare Acquisitions Cor
DFPH
(Other OTC)

Recent

price

2.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2023
2024
2025
TTM
FRC
0.01
0.01
0.01
- -
Revenue per Share
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
Dividend per Share
-0.01
-0.01
-0.01
-0.01
Book Value per Share
- -
0.01
0.01
- -
Tangible Book Value per Share
215
215
217
217
Basic Weighted Avg Shares
1
1
1
1
Sales/Revenue/Turnover
-20.1
-21.14
-36.8
-95.05
Operating Margin (%)
- -
- -
- -
- -
Depreciation Expense
-1
- -
- -
-1
Net Income, GAAP
- -
- -
- -
- -
Effective Tax Rate (%)
-58.74
-22.55
-39.37
-92.57
Profit Margin (%)
1
2
1
1
Working Capital
- -
- -
- -
- -
LT Debt
1
2
1
1
Total Equity
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
217
217
217
Market Capitalization
290
436
436

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'26
Mar'26
Total Current Assets
1
2
1
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-24.22%
Free Cash Flow
- -
- -
82.89%
Net Income, GAAP
- -
- -
35.63%
Sales/Revenue/Turnover
- -
- -
-22.33%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
1
1
2025
- -
- -
- -
- -
1
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
DFP Healthcare Acquisitions Corp. (DFPH) operates as a blank check company focused on effecting mergers, capital stock exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations, primarily targeting healthcare and healthcare-related businesses encompassing services, therapeutics, devices, diagnostics, and animal health. The company offers no proprietary products or services beyond its special purpose acquisition vehicle structure, which facilitates initial public offerings and subsequent combinations with operating entities in the healthcare sector. Incorporated in 2019 and headquartered in New York, New York, it conducts operations principally in the United States and other developed markets, with a sponsor affiliation to Deerfield Management Company, L.P., and involvement from healthcare executive Richard Barasch. In November 2021, DFP Healthcare Acquisitions Corp. completed a reverse merger business combination with The Oncology Institute, Inc. (TOI), a value-based oncology care provider, valuing the combined entity at an enterprise value of approximately $842 million and enabling TOI to list on Nasdaq under the ticker TOI. This transaction included a $275 million private investment in public equity (PIPE) from investors such as Fidelity Management & Research Company LLC, Deerfield Management, and Redmile Group, LLC, alongside approximately $334 million in total cash proceeds, of which $133 million supported TOI's growth in de novo clinics and acquisitions across California, Nevada, Arizona, and Florida. Post-merger, the DFPH ticker appears associated with DFP Holdings Limited, a separate Taiwan-based entity providing online and offline educational services in business management training and self-media production via platforms like dfpschool.qdm.tw, though no direct operational linkage to the original SPAC activities is evident.

Company News

APIChatGPT
  • The Oncology Institute Physician, Dr. John Khoury, Receives 40 Under 40 in Cancer Award

  • DFP Healthcare Acquisitions Corp. Announces Special Meeting Date to Approve Proposed Business Combination with The Oncology Institute

  • DFP Healthcare Acquisitions Corp. Announces Proposed Business Combination With The Oncology Institute

  • Trade-In Lame 0.5% Bonds For Secure Yields Up To 7.5%